Skip to main content

The Clinical Approach to the Patients with Low HDL and Elevated Plasma Triglyceride

  • Chapter
Drugs Affecting Lipid Metabolism

Part of the book series: Medical Science Symposia Series ((MSSS,volume 2))

  • 84 Accesses

Abstract

High triglyceride/low HDL-C syndrome has been discussed in this report. Primary and secondary causes have been reviewed and relationships with cardiovascular disease evaluated. Finally useful advices for the clinical approach to this kind of patients have been suggested.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Assmann G, Betteridge DJ, Gotto AM, Steiner — (1991) ‘Management of hypertriglyceridemia patients. A. Treatment classification and goals’, Am — Cardiol 68, 30A–34A.

    Article  CAS  Google Scholar 

  • Austin MA, Goto Y, Lenfant C, Tyroler HA (1991) ‘Epidemiology’, Am — Cardiol 68, 22A–25A.

    Article  CAS  Google Scholar 

  • Averna MR, Barbagallo CM, Galione — et al (1989) ‘Serum apolipoprotein profile of hypertriglyceridemic patients with chronic renal failure on hemodialytic therapy:a comparison with type IV hyperlipoproteinemic patients’, Metabolism 38, 601–602.

    Article  PubMed  CAS  Google Scholar 

  • Averna MR, Barbagallo CM, Galione — et al (1990) ‘Lipids and lipo-apoproteins in patients with chronic renal failure on hemodialytic therapy’, in Crepaldi G, Tiengo A, Enzi — (Eds), Diabetes, Obesity and Hyperlipidemias-IV, Elsevier Science Publishers B.V., Amsterdam, pp. 41–44.

    Google Scholar 

  • Averna MR, Barbagallo CM, Ocello — et al (1992) ‘Lp(a) levels in patients undergoing aorto-coronary bypass surgery’, Eur Heart — in press.

    Google Scholar 

  • Barbagallo CM, Averna MR, Amato — et al (1990) ‘Apolipoprotein profile in type II diabetic patients with and without coronary heart disease’, Acta Diab Lat 27, 371–377.

    Article  CAS  Google Scholar 

  • Barbagallo CM, Averna MR, Cavera — et al (1992) ‘Lipidi ed apoproteine plasmatiche: influenza del fumo di sigaretta’, Rec Prog Med 83, 127–130.

    CAS  Google Scholar 

  • Barbir M, Wile D, Trayner I, Aber VR, Thompson GR (1988) ‘High prevalence of hypertriglyceridemia and apolipoprotein abnormalities in coronary artery disease’, Br Heart — 60, 397–403.

    Article  PubMed  CAS  Google Scholar 

  • Betteridge DJ (1989) ‘Lipids, diabetes, and vascular disease: the time of act’, Diab Med 6, 195–218.

    Article  CAS  Google Scholar 

  • Carlson LA, Bottinger LE (1985) ‘Risk factors for ischemic heart disease in men and in women. Results of the 19-year follow-up of the Stockholm Prospective Study’, Acta Med Scand 218, 207–211.

    Article  PubMed  CAS  Google Scholar 

  • Depres JP, Moorjani S, Ferland — et al (1989) ‘Adipose tissue distribution and plasma lipoprotein levels in obese women. Importance of intra-abdominal fat’, Arteriosclerosis 9, 203–210.

    Article  Google Scholar 

  • Gordon DJ, Probstfield JL, Garrison RJ et al (1989) ‘High-Density Lipoprotein cholesterol and cardiovascular disease’, Circulation 79, 8–15.

    Article  PubMed  CAS  Google Scholar 

  • Kannel WB, Wolf Pa, Castelli WP, D’Agostino — (1987) ‘Fibrinogen and risk for cardiovascular disease’, JAMA 258, 1183–1186.

    Article  PubMed  CAS  Google Scholar 

  • Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama — (1986) ‘Lp(a) lipoprotein as — risk factor for coronary heart disease and cerebral infarction’, Atherosclerosis 59, 199–204.

    Article  PubMed  CAS  Google Scholar 

  • Notarbartolo A, Averna MR, Barbagallo CM (1991) ‘Secondary hyperlipoproteinemias ang aging’, Arch Gerontol Geriatr suppl 2, 569–574.

    Google Scholar 

  • Reaven GM (1988) ‘Role of insulin resistance in human disease’, Diabetes 37, 1595–1607.

    Article  PubMed  CAS  Google Scholar 

  • Sandkamp M, Funke H, Schulte H, Kohler E, Assmann — (1990) ‘Lipoprotein(a) is an indipendent risk factor for myocadial infarction at — young age’, Clin Chem 36, 20–23.

    PubMed  CAS  Google Scholar 

  • Williams RR, Hunt SC, Hasstedt SJ et al (1992) ‘Are there interactions and relations between genetic and enviromental factors predisposing to high blood pressure?’, Hypertension 18, suppl I, 129–137.

    Google Scholar 

  • Vergani C, Bettale — (1981) ‘Familial hypo-alpha-lipoproteinemia’, Clin Chim Acta 114, 45–52.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Averna, M.R., Barbagallo, C.M., Notarbartolo, A. (1993). The Clinical Approach to the Patients with Low HDL and Elevated Plasma Triglyceride. In: Catapano, A.L., Gotto, A.M., Smith, L.C., Paoletti, R. (eds) Drugs Affecting Lipid Metabolism. Medical Science Symposia Series, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1703-6_43

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-1703-6_43

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4746-3

  • Online ISBN: 978-94-011-1703-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics